SIGSigma Health

Sigma Healthcare shares fell sharply after investors sold into the release of its results, which showed 20% earnings growth but apparently disappointed the market's higher expectations or triggered profit-taking after a strong prior run.

Sigma Healthcare's stock rose sharply after the company withdrew from the multi-billion-dollar Boots sale process, which investors viewed positively.

Sigma Healthcare shares fell 5.5% as investor concerns grew over its reported $10-14 billion potential acquisition of UK pharmacy chain Boots, with shareholders split on the deal's risks.

Sigma Healthcare (SIG.AX) shares jumped 7.8% after reporting a strong FY25 result with 82% profit growth and double-digit sales growth, beating expectations.

No specific company news explains the drop; broad market weakness from bank stocks dragged the ASX 200 down.

Insufficient evidence to determine the cause of the price move.

Insufficient evidence to determine the cause of the price move.

Sigma Healthcare completed its merger with Chemist Warehouse, leading to a strong re-rating on its first day of trading as the merged entity.

Sigma Healthcare completed its merger with Chemist Warehouse, and the stock rose on the first day of trading post-merger.

Sigma Healthcare shares surged after the ACCC cleared its $8.8 billion merger with Chemist Warehouse.

Sigma Healthcare's shares surged on investor optimism over concessions offered for its Chemist Warehouse merger, pushing the stock to all-time highs.

Investors reacted positively to Sigma Healthcare's concessions offered for its Chemist Warehouse merger, signaling progress in the deal.